Efficacy of rechallenge immunotherapy after immune monotherapy resistance in patients with advanced non-small cell lung cancer

被引：0
|
作者：
Manyi Xu
Yue Hao
Zheng Shi
Zhengbo Song
机构：
[1] Zhejiang Chinese Medical University,The Second Clinical Medical College
[2] Zhejiang Cancer Hospital,Department of Clinical Trail
[3] Chinese Academy of Sciences,Hangzhou Institute of Medicine (HIM)
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Immunotherapy; Resistance; Immune checkpoint inhibitors; Rechallenge;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：17987 / 17995
页数：8
相关论文
共 50 条
  • [1] Efficacy of rechallenge immunotherapy after immune monotherapy resistance in patients with advanced non-small cell lung cancer
    Xu, Manyi
    Hao, Yue
    Shi, Zheng
    Song, Zhengbo
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (20) : 17997 - 18004
  • [2] Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Lin, Gen
    Wang, Zhijie
    Chu, Qian
    Hu, Yi
    Huang, Dingzhi
    Wang, Jun
    Yang, Fan
    Zhong, Wenzhao
    Zhou, Chengzhi
    Zhu, Bo
    Ai, Xinghao
    Cao, Baoshan
    Cao, Yabing
    Chen, Mingqiu
    Chen, Xiaohui
    Chu, Tianqing
    Duan, Jianchun
    Fan, Yun
    Fang, Yong
    Feng, Shuitu
    Feng, Weineng
    Guo, Hui
    Han, Chengbo
    He, Yong
    Hong, Shaodong
    Hu, Jie
    Huang, Meijuan
    Huang, Yan
    Jiang, Da
    Jiang, Kan
    Jiang, Richeng
    Jin, Bo
    Jin, Shi
    Li, Jisheng
    Li, Min
    Li, Ziming
    Li, Chao
    Lin, Jie
    Liu, Anwen
    Liu, Si-Yang Maggie
    Yutao, Liu
    Liu, Zhefeng
    Liu, Zhe
    Liu, Zhenhua
    Liu, Zhentian
    Liu, Zhigang
    Lu, Yuping
    Lv, Tangfeng
    Ma, Zhiyong
    Miao, Qian
    THORACIC CANCER, 2024, 15 (05) : 419 - 426
  • [3] Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer
    Cappuzzo, Federico
    Morabito, Alessandro
    Normanno, Nicola
    Bidoli, Paolo
    Del Conte, Alessandro
    Giannetta, Laura
    Montanino, Agnese
    Mazzoni, Francesca
    Buosi, Roberta
    Burgio, Marco Angelo
    Cerea, Giulio
    Chiari, Rita
    Cortinovis, Diego
    Finocchiaro, Giovanna
    Foltran, Luisa
    Migliorino, Maria Rita
    Tiseo, Marcello
    Ferrari, Silvia
    De Marinis, Filippo
    LUNG CANCER, 2016, 99 : 31 - 37
  • [4] Osimertinib rechallenge in advanced EGFR non-small cell lung cancer patients
    Uy, Natalie F.
    Tratt, Micah
    Eaton, Keith D.
    Santana-Davila, Rafael
    Baik, Christina S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study
    Feng, Jia
    Chen, Xinyi
    Wei, Jiayan
    Weng, Yiming
    Wang, Jingsong
    Wang, Tong
    Song, Qibin
    Min, Peng
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [6] Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study
    Jia Feng
    Xinyi Chen
    Jiayan Wei
    Yiming Weng
    Jingsong Wang
    Tong Wang
    Qibin Song
    Peng Min
    Scientific Reports, 14
  • [7] Efficacy and predictors of rechallenge with immune checkpoint inhibitors in non-small cell lung cancer
    Takahara, Yutaka
    Tanaka, Takuya
    Ishige, Yoko
    Shionoya, Ikuyo
    Yamamura, Kouichi
    Sakuma, Takashi
    Nishiki, Kazuaki
    Nakase, Keisuke
    Nojiri, Masafumi
    Kato, Ryo
    Shinomiya, Shohei
    Fujimoto, Yuki
    Oikawa, Taku
    Mizuno, Shiro
    THORACIC CANCER, 2022, 13 (04) : 624 - 630
  • [8] Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer
    Katayama, Yuki
    Shimamoto, Takayuki
    Yamada, Tadaaki
    Takeda, Takayuki
    Yamada, Takahiro
    Shiotsu, Shinsuke
    Chihara, Yusuke
    Hiranuma, Osamu
    Iwasaku, Masahiro
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [9] EFFICACY AND SAFETY OF GEFITINIB AS MONOTHERAPY FOR CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    WANG Meng-zhao
    中华医学杂志(英文版), 2006, (01) : 63 - 68
  • [10] EFFICACY AND SAFETY OF GEFITINIB AS MONOTHERAPY FOR CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    WANG Mengzhao LI Longyun WANG Shulan ZHANG Xiaotong ZHONG Wei and ZHANG LiDepartment of Respiratory Diseases Peking Union Medical College Hospital Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China
    Chinese Medical Journal, 2006, (01) : 63 - 68
12345